False daptomycin-nonsusceptible MIC results by microscan panel PC 29 relative to etest results for Staphylococcus aureus and Enterococci

Journal of Clinical Microbiology

Volumn 51, Issue 1, 2013, Pages 281-283

  Palavecino, Elizabeth L ^a   Burnell, Jacqueline M ^a  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANALYTIC METHOD; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL STRAIN; BACTERIUM DETECTION; BACTERIUM ISOLATE; BACTERIUM ISOLATION; BROTH DILUTION; CONTROLLED STUDY; CORRELATION ANALYSIS; ENTEROCOCCUS FAECALIS; ENTEROCOCCUS FAECIUM; EPSILOMETER TEST; MICROSCAN PANEL PC 29; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; STAPHYLOCOCCUS AUREUS;

ANTI-BACTERIAL AGENTS; DAPTOMYCIN; DIAGNOSTIC ERRORS; ENTEROCOCCUS FAECALIS; ENTEROCOCCUS FAECIUM; HUMANS; MICROBIAL SENSITIVITY TESTS; STAPHYLOCOCCUS AUREUS;

ENTEROCOCCUS FAECALIS; ENTEROCOCCUS FAECIUM; STAPHYLOCOCCUS AUREUS;

EID: 84871693269     PISSN: 00951137     EISSN: 1098660X     Source Type: Journal    
DOI: 10.1128/JCM.01721-12     Document Type: Article

References (12)

1. Hayden MK, Rezai K, Hayes RA, Lolans K, Quinn JP, Weinstein RA. 2005. Development of daptomycin resistance in vivo in methicillin- resistantStaphylococcus aureus. J. Clin. Microbiol. 43:5285-5287. (Pubitemid 41484040)
2. Hirschwerk D, Ginocchio CC, Bythrowm M, Condon S. 2006. Diminished susceptibility to daptomycin accompanied by clinical failure in a patient with methicillin-resistant Staphylococcus aureus bacteremia. Infect. Control Hosp. Epidemiol. 27:315-317.
3. Kelesidis T, Humphries R, Uslan DZ, Pegues DA. 2011. Daptomycin nonsusceptible enterococci: an emerging challenge for clinicians. Clin. Infect. Dis. 52:228-234.
4. CLSI. 2012. Performance standards for antimicrobial susceptibility testing; 20th informational supplement. CLSI document M100-S22. Clinical and Laboratory Standards Institute, Wayne, PA.
5. Kamboj M, Cohen N, Gilhuley K, Babady NE, Seo SK, Sepkowitz KA. 2011. Emergence of daptomycin-resistant VRE: experience of a single institution. Infect. Control Hosp. Epidemiol. 32:391-394.
6. Siemens. 2011. Enterococcus faecium with reduced susceptibility to daptomycin. Technical support bulletin 182. Siemens Healthcare Diagnostics Inc., West Sacramento, CA.
7. Keel RA, Sutherland CA, Aslanzabeh J, Nicolau DP, Kuti JL. 2010. Correlation between vancomycin and daptomycin MIC values for methicillin-resistant and methicillin-susceptible Staphylococcus aureus by 3 testing methodologies. Diagn. Microbiol. Infect. Dis. 68:326-329.
8. Koeth LM, DiFranco JM. 2010. Comparison of daptomycin Etest MICs on Mueller Hinton, IsoSensitest and brain heart infusion agars in Europe against 20 Staphylococcus aureus isolates. Eur. J. Clin. Microbiol. Infect. Dis. 29:1261-1264.
9. Sader HS, Rhomberg PR, Jones RN. 2009. Nine-hospital study comparing broth microdilution and Etest method results for vancomycin and daptomycin against methicillin-resistant Staphylococcus aureus. Antimicrob. Agents Chemother. 53:3162-3165.
10. Friedrich L, Thorne G, Steenbergen JN, Anastasiou D, Koeth L. 2009. Evidence for daptomycin Etest lot-related MIC elevations for Staphylococcus aureus. Diagn. Microbiol. Infect. Dis. 65:306-311.
11. Kruzel MC, Lewis CT, Welsh KJ, Lewis EM, Dundas NE, Mohr JF, Armitige LY, Wanger A. 2011. Determination of vancomycin and daptomycin MICs by different testing methods for methicillin-resistant Staphylococcus aureus. J. Clin. Microbiol. 49:2272-2273.
12. European Committee on Antimicrobial Susceptibility Testing (EUCAST). 2012. MIC distributions. http://www.eucast.org/mic-distributions/. Accessed 23 September 2012.